Investigating the gut microbiome and metabolome following treatment with artificial sweeteners acesulfame potassium and saccharin in young adult Wistar rats.


Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 27 01 2022
revised: 07 04 2022
accepted: 06 05 2022
pubmed: 20 5 2022
medline: 18 6 2022
entrez: 19 5 2022
Statut: ppublish

Résumé

To elucidate if artificial sweeteners modify fecal bacterial composition and the fecal and plasma metabolomes, Wistar rats from both sexes were treated for 28 days with acesulfame potassium (40 and 120 mg/kg body weight) and saccharin (20 and 100 mg/kg body weight). Targeted MS-based metabolome profiling (plasma and feces) and fecal 16S gene sequencing were conducted. Both sweeteners exhibited only minor effects on the fecal metabolome and microbiota. Saccharin treatment significantly altered amino acids, lipids, energy metabolism and specifically, bile acids in the plasma metabolome. Additionally, sex-specific differences were observed for conjugated primary and secondary bile acids. Acesulfame potassium treated male rats showed larger alterations in glycine conjugated primary and secondary bile-acids than females. Other changes in the plasma metabolome were more profound for saccharin than acesulfame potassium, for both sexes. Changes in conjugated bile-acids in plasma, which are often associated with microbiome changes, and the absence of similarly large changes in microbiota suggest an adaptative change of the latter, rather than toxicity. Further studies with a high resolution 16S sequencing data and/or metagenomics approach, with particular emphasis on bile acids, will be required to explore the mechanisms driving this metabolic outcome of saccharin in Wistar rats.

Identifiants

pubmed: 35588986
pii: S0278-6915(22)00321-0
doi: 10.1016/j.fct.2022.113123
pii:
doi:

Substances chimiques

Bile Acids and Salts 0
Sweetening Agents 0
Thiazines 0
Saccharin FST467XS7D
acetosulfame MA3UYZ6K1H

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113123

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Aishwarya Murali (A)

BASF SE, Ludwigshafen am Rhein, Germany. Electronic address: aishwarya.murali@basf.com.

Varun Giri (V)

BASF SE, Ludwigshafen am Rhein, Germany.

Hunter James Cameron (HJ)

BASF Corporation Computational Biology (RTP), Research Triangle Park, USA.

Saskia Sperber (S)

BASF SE, Ludwigshafen am Rhein, Germany.

Franziska Maria Zickgraf (FM)

BASF SE, Ludwigshafen am Rhein, Germany.

Volker Haake (V)

BASF Metabolome Solutions GmbH, Berlin, Germany.

Peter Driemert (P)

BASF Metabolome Solutions GmbH, Berlin, Germany.

Tilmann Walk (T)

BASF Metabolome Solutions GmbH, Berlin, Germany.

Hennicke Kamp (H)

BASF Metabolome Solutions GmbH, Berlin, Germany.

Ivonne McM Rietjens (IM)

Division of Toxicology, Wageningen University, 6700 EA, Wageningen, the Netherlands.

Bennard van Ravenzwaay (B)

Division of Toxicology, Wageningen University, 6700 EA, Wageningen, the Netherlands.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH